{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:43:38Z","timestamp":1782726218082,"version":"3.54.5"},"reference-count":121,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>Myopia is a major cause of visual impairment. Its prevalence is growing steadily, especially in East Asia. Despite the immense disease and economic burden, there are currently no Food and Drug Administration-approved drugs for myopia. This review aims to summarise pharmaceutical interventions of myopia at clinical and preclinical stages in the last decade and discuss challenges for preclinical myopia drugs to progress to clinical trials. Atropine and oral 7-methylxanthine are shown to reduce myopia progression in human studies. The former has been extensively studied and is arguably the most successful medication. However, it has side effects and trials on low-dose atropine are ongoing. Other pharmaceutical agents being investigated at a clinical trial level include ketorolac tromethamine, oral riboflavin and BHVI2 (an experimental drug). Since the pathophysiology of myopia is not fully elucidated, numerous drugs have been tested at the preclinical stage and can be broadly categorised based on the proposed mechanisms of myopisation, namely antimuscarinic, dopaminergic, anti-inflammatory and more. However, several agents were injected intravitreally or subconjunctivally, hindering their progress to human trials. Furthermore, with atropine being the most successful medication available, future preclinical interventions should be studied in combination with atropine to optimise the treatment of myopia.<\/jats:p>","DOI":"10.1136\/bjophthalmol-2018-313798","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T21:24:27Z","timestamp":1558041867000},"page":"1539-1548","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Current and emerging pharmaceutical interventions for myopia"],"prefix":"10.1136","volume":"103","clinical-trial-number":[{"clinical-trial-number":"nct03140358","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03552016","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8941-8846","authenticated-orcid":false,"given":"Kritchai","family":"Vutipongsatorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ohno-Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"2020050713023712000_103.11.1539.1","doi-asserted-by":"crossref","unstructured":"Stevens GA , White RA , Rupert RA , et al . Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health 2013;1.doi:10.1016\/S2214-109X(13)70113-X","DOI":"10.1016\/S2214-109X(13)70113-X"},{"key":"2020050713023712000_103.11.1539.2","doi-asserted-by":"crossref","unstructured":"LLK L , Shih YF , Hsiao CK , et al . Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Annals of the Academy of Medicine, Singapore 2004;33.","DOI":"10.47102\/https:\/\/doi.org\/10.47102\/annals-acadmedsg.V33N1p27"},{"key":"2020050713023712000_103.11.1539.3","doi-asserted-by":"publisher","DOI":"10.1097\/01.opx.0000195567.88641.af"},{"key":"2020050713023712000_103.11.1539.4","first-page":"728","volume-title":"Global cost of correcting vision impairment from uncorrected refractive error","volume":"90","author":"Fricke","year":"2012"},{"key":"2020050713023712000_103.11.1539.5","doi-asserted-by":"crossref","unstructured":"Kumaran A , Htoon HM , Tan D , et al . Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes. Invest Ophthalmol Vis Sci 2015;56.doi:10.1167\/iovs.14-14716","DOI":"10.1167\/iovs.14-14716"},{"key":"2020050713023712000_103.11.1539.6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0954-6820.1982.tb00407.x","article-title":"Rebound phenomena following withdrawal of long-term beta-adrenoceptor blockade","volume":"665","author":"Hjemdahl","year":"1982","journal-title":"Acta Med Scand Suppl"},{"key":"2020050713023712000_103.11.1539.7","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-199906000-00016"},{"key":"2020050713023712000_103.11.1539.8","doi-asserted-by":"crossref","unstructured":"Chia A , Lu Q , Tan D . Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology 2016;123.","DOI":"10.1016\/j.ophtha.2015.07.004"},{"key":"2020050713023712000_103.11.1539.9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (lamp) study","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"2020050713023712000_103.11.1539.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.03.018"},{"key":"2020050713023712000_103.11.1539.11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ctim.2014.03.004","article-title":"The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control","volume":"22","author":"Cheng","year":"2014","journal-title":"Complement Ther Med"},{"key":"2020050713023712000_103.11.1539.12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ctim.2008.04.007","article-title":"A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial","volume":"16","author":"Liang","year":"2008","journal-title":"Complement Ther Med"},{"key":"2020050713023712000_103.11.1539.13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12177-008-9013-3","article-title":"Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study","volume":"1","author":"Trier","year":"2008","journal-title":"J Ocul Biol Dis Infor"},{"key":"2020050713023712000_103.11.1539.14","doi-asserted-by":"crossref","unstructured":"Wallman J , Winawer J . Homeostasis of eye growth and the question of myopia. Neuron 2012;74.doi:10.1016\/j.neuron.2012.03.018","DOI":"10.1016\/j.neuron.2012.03.018"},{"key":"2020050713023712000_103.11.1539.15","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6989(94)00233-C"},{"key":"2020050713023712000_103.11.1539.16","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1998.0587"},{"key":"2020050713023712000_103.11.1539.17","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.27.6.371.18188"},{"key":"2020050713023712000_103.11.1539.18","unstructured":"Caulfield MP , Birdsall NJ . International Union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998;50."},{"key":"2020050713023712000_103.11.1539.19","first-page":"137","volume-title":"Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks","volume":"81","author":"Schmid","year":"2004"},{"key":"2020050713023712000_103.11.1539.20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0796"},{"key":"2020050713023712000_103.11.1539.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00188-7"},{"key":"2020050713023712000_103.11.1539.22","doi-asserted-by":"crossref","unstructured":"Carr BJ , Mihara K , Ramachandran R , et al . Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha 2A -Adrenoceptors In Vitro. Invest Ophthalmol Vis Sci 2018;59.doi:10.1167\/iovs.17-22562","DOI":"10.1167\/iovs.17-22562"},{"key":"2020050713023712000_103.11.1539.23","unstructured":"McBrien NA , Moghaddam HO , Reeder AP . Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 1993;34."},{"key":"2020050713023712000_103.11.1539.24","doi-asserted-by":"publisher","DOI":"10.1017\/S0952523800012360"},{"key":"2020050713023712000_103.11.1539.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.2.704"},{"key":"2020050713023712000_103.11.1539.26","doi-asserted-by":"publisher","DOI":"10.1017\/S0952523800011287"},{"key":"2020050713023712000_103.11.1539.27","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6989(94)00221-7"},{"key":"2020050713023712000_103.11.1539.28","doi-asserted-by":"crossref","unstructured":"Ward AH , Siegwart JT , Frost MR , et al . Intravitreally-administered dopamine D2-like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews. Visual Neuroscience 2017;34.doi:10.1017\/S0952523816000195","DOI":"10.1017\/S0952523816000195"},{"key":"2020050713023712000_103.11.1539.29","doi-asserted-by":"crossref","unstructured":"Zhang S , Yang J , Reinach PS , et al . Dopamine receptor subtypes mediate opposing effects on form deprivation myopia in pigmented guinea pigs. Invest. Ophthalmol. Vis. Sci. 2018;59.doi:10.1167\/iovs.17-21574","DOI":"10.1167\/iovs.17-21574"},{"key":"2020050713023712000_103.11.1539.30","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.16.2.152.5090"},{"key":"2020050713023712000_103.11.1539.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.08.021"},{"key":"2020050713023712000_103.11.1539.32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.preteyeres.2017.06.003","article-title":"Dopamine signaling and myopia development: what are the key challenges","volume":"61","author":"Zhou","year":"2017","journal-title":"Progress in Retinal and Eye Research"},{"key":"2020050713023712000_103.11.1539.33","doi-asserted-by":"publisher","DOI":"10.1016\/0012-1606(91)90288-E"},{"key":"2020050713023712000_103.11.1539.34","first-page":"2217","article-title":"Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes","volume":"39","author":"Lind","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713023712000_103.11.1539.35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ebiom.2016.07.021","article-title":"Role of chronic inflammation in myopia progression: Clinical evidence and experimental validation","volume":"10","author":"Lin","year":"2016","journal-title":"EBioMedicine"},{"key":"2020050713023712000_103.11.1539.36","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4835(91)90027-C"},{"key":"2020050713023712000_103.11.1539.37","unstructured":"Cottriall CL , McBrien NA . The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest Ophthalmol Vis Sci 1996;37."},{"key":"2020050713023712000_103.11.1539.38","unstructured":"Ringold S . Safety and Efficacy of 2% Pirenzepine Ophthalmic Gel in Children With Myopia: A 1-Year, Multicenter, Double-Masked, Placebo-Controlled Parallel Study. JAMA 2005;293."},{"key":"2020050713023712000_103.11.1539.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.06.038"},{"key":"2020050713023712000_103.11.1539.40","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.nano.2017.05.001","article-title":"Ion-paired pirenzepine-loaded micelles as an ophthalmic delivery system for the treatment of myopia","volume":"13","author":"Li","year":"2017","journal-title":"Nanomedicine"},{"key":"2020050713023712000_103.11.1539.41","doi-asserted-by":"crossref","unstructured":"Abraham SV . Control of myopia with tropicamide. J Pediatr Ophthalmol 1966;3.","DOI":"10.3928\/0191-3913-19661101-04"},{"key":"2020050713023712000_103.11.1539.42","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00007611-196209000-00011","article-title":"Prophylatic management of progressive myopia","volume":"55","author":"GOSTIN","year":"1962","journal-title":"South Med J"},{"key":"2020050713023712000_103.11.1539.43","unstructured":"Gallemore RP , Hughes BA , Miller SS . Light-induced responses of the retinal pigment epithelium. In: Marmor MF , Wolfensberger TJ , eds. The retinal pigment epithelium. New York: Oxford University Press, 1998: 175\u201398."},{"key":"2020050713023712000_103.11.1539.44","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.045328"},{"key":"2020050713023712000_103.11.1539.45","first-page":"1370","volume-title":"Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine","volume":"83","author":"Trier","year":"1999"},{"key":"2020050713023712000_103.11.1539.46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ebiom.2018.01.024","article-title":"Allergic Conjunctivitis-induced retinal inflammation promotes myopia progression","volume":"28","author":"Wei","year":"2018","journal-title":"EBioMedicine"},{"key":"2020050713023712000_103.11.1539.47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1442-9071.2001.00400.x","article-title":"Effects of a non-steroidal (ketorolac tromethamine) and a steroidal (dexamethasone) anti-inflammatory drug on refractive state and ocular growth","volume":"29","author":"Luu","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"2020050713023712000_103.11.1539.48","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(02)00063-0"},{"key":"2020050713023712000_103.11.1539.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01229.x"},{"key":"2020050713023712000_103.11.1539.50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2017.08.019","article-title":"Riboflavin and ultraviolet A irradiation for the prevention of progressive myopia in a guinea pig model","volume":"165","author":"Li","year":"2017","journal-title":"Exp Eye Res"},{"key":"2020050713023712000_103.11.1539.51","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050120046017"},{"key":"2020050713023712000_103.11.1539.52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0161-6420(95)31038-X","article-title":"Association of intraocular pressure and myopia in children","volume":"102","author":"Quinn","year":"1995","journal-title":"Ophthalmology"},{"key":"2020050713023712000_103.11.1539.53","doi-asserted-by":"publisher","DOI":"10.1016\/0275-5408(95)00064-X"},{"key":"2020050713023712000_103.11.1539.54","first-page":"1","article-title":"Myopia progression in young school children: a prospective study of myopia progression and the effect of a trial with bifocal lenses and \u03b2 blocker eye drops","volume":"200","author":"Jensen","year":"1991","journal-title":"Acta Ophthalmol Suppl"},{"key":"2020050713023712000_103.11.1539.55","first-page":"785","article-title":"\u03b1-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study","volume":"23","author":"Liu","year":"2017","journal-title":"Mol Vis"},{"key":"2020050713023712000_103.11.1539.56","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1167\/iovs.17-22890","article-title":"Effects of topical latanoprost on intraocular pressure and myopia progression in young guinea pigs","volume":"59","author":"El-Nimri","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713023712000_103.11.1539.57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/bcpt.13017","article-title":"Prostaglandin F2\u03b1 receptor modulation affects eye development in guinea pigs","volume":"123","author":"Yang","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2020050713023712000_103.11.1539.58","doi-asserted-by":"publisher","DOI":"10.1038\/266066a0"},{"key":"2020050713023712000_103.11.1539.59","unstructured":"Raviola E , Wiesel TN . Effect of dark-rearing on experimental myopia in monkeys. Invest Ophthalmol Vis Sci 1978;17."},{"key":"2020050713023712000_103.11.1539.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2005.06.036"},{"key":"2020050713023712000_103.11.1539.61","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0039-6257(99)00087-9","article-title":"Axial length increase in lid-sutured rabbits","volume":"44 Suppl 1","author":"Verolino","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"2020050713023712000_103.11.1539.62","doi-asserted-by":"publisher","DOI":"10.3109\/02713688709034870"},{"key":"2020050713023712000_103.11.1539.63","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90872-1"},{"key":"2020050713023712000_103.11.1539.64","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-200402000-00008"},{"key":"2020050713023712000_103.11.1539.65","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1002\/term.2275","article-title":"Establishment of novel therapy to reduce progression of myopia in rats with experimental myopia by fibroblast transplantation on sclera","volume":"12","author":"Shinohara","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"2020050713023712000_103.11.1539.66","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6989(88)90113-7"},{"key":"2020050713023712000_103.11.1539.67","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-199905000-00019"},{"key":"2020050713023712000_103.11.1539.68","doi-asserted-by":"crossref","unstructured":"Li W , Lan W , Yang S , et al . The effect of spectral property and intensity of light on natural refractive development and compensation to negative lenses in guinea pigs. Invest. Ophthalmol. Vis. Sci. 2014;55.doi:10.1167\/iovs.13-13802","DOI":"10.1167\/iovs.13-13802"},{"key":"2020050713023712000_103.11.1539.69","doi-asserted-by":"crossref","unstructured":"Smith 3, Earl L, hUNG L, Arumugam B, Huang J. Negative lens-induced myopia in infant monkeys: effects of high ambient lighting. Invest Ophthalmol Vis Sci 2013;54.","DOI":"10.1167\/iovs.13-11713"},{"key":"2020050713023712000_103.11.1539.70","unstructured":"Kee C , Marzani D , Wallman J . Differences in time course and visual requirements of ocular responses to lenses and Diffusers. Invest Ophthalmol Vis Sci 2001;42."},{"key":"2020050713023712000_103.11.1539.71","doi-asserted-by":"publisher","DOI":"10.1017\/S0952523800001565"},{"key":"2020050713023712000_103.11.1539.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2013.02.007"},{"key":"2020050713023712000_103.11.1539.73","doi-asserted-by":"publisher","DOI":"10.1038\/11167"},{"key":"2020050713023712000_103.11.1539.74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0003-3472(74)80060-6","article-title":"Spatial and non-spatial discrimination reversal (SDR) learning in the guinea pig","volume":"22","author":"Jonson","year":"1974","journal-title":"Anim Behav"},{"key":"2020050713023712000_103.11.1539.75","doi-asserted-by":"crossref","unstructured":"Chase J . The evolution of retinal vascularization in mammals. A comparison of vascular and avascular retinae. Ophthalmology 1982;89.","DOI":"10.1016\/S0161-6420(82)34608-4"},{"key":"2020050713023712000_103.11.1539.76","doi-asserted-by":"publisher","DOI":"10.1037\/0735-7044.108.5.993"},{"key":"2020050713023712000_103.11.1539.77","doi-asserted-by":"publisher","DOI":"10.1053\/j.jepm.2007.03.012"},{"key":"2020050713023712000_103.11.1539.78","doi-asserted-by":"crossref","unstructured":"Straznicky C , Chehade M . The formation of the area centralis of the retinal ganglion cell layer in the chick. Development 1987;100.","DOI":"10.1242\/dev.100.3.411"},{"key":"2020050713023712000_103.11.1539.79","unstructured":"Koch T . Anatomy of the chicken and domestic birds. 1st edn. Ames, Iowa: Iowa State Univ. Pr, 1973."},{"key":"2020050713023712000_103.11.1539.80","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6989(00)00138-3"},{"key":"2020050713023712000_103.11.1539.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2008.10.008"},{"key":"2020050713023712000_103.11.1539.82","unstructured":"McBrien NA , Cornell LM , Gentle A . Structural and ultrastructural changes to the sclera in a mammalian model of high myopia. Invest Ophthalmol Vis Sci 2001;42."},{"key":"2020050713023712000_103.11.1539.83","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cxo.12312","article-title":"Animal models in myopia research","volume":"98","author":"Schaeffel","year":"2015","journal-title":"Clin Exp Optom"},{"issue":"Suppl. 1","key":"2020050713023712000_103.11.1539.84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/vop.12070","article-title":"Ocular comparative anatomy of the family Rodentia","volume":"16","author":"Rodriguez-Ramos Fernandez","year":"2013","journal-title":"Vet Ophthalmol"},{"key":"2020050713023712000_103.11.1539.85","unstructured":"Beyerlein L . The gross and microscopic structure of the hamster eye with special reference to accomodation. Oregon State University, 1953."},{"key":"2020050713023712000_103.11.1539.86","doi-asserted-by":"publisher","DOI":"10.1586\/eop.10.67"},{"key":"2020050713023712000_103.11.1539.87","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002642"},{"key":"2020050713023712000_103.11.1539.88","unstructured":"Iuvone PM . Neurotransmitters and receptors: dopamine A2. In: Dartt DA , ed. Encyclopedia of the eye. Cambridge, MA: Oxford\/Academic Press, 2010: 130\u20135."},{"key":"2020050713023712000_103.11.1539.89","doi-asserted-by":"crossref","unstructured":"Metlapally S , McBrien NA . The effect of pirenzepine on positive- and Negative-Lens\u2013Induced refractive error and ocular growth in chicks. Invest. Ophthalmol. Vis. Sci. 2010;51.doi:10.1167\/iovs.09-4431","DOI":"10.1167\/iovs.09-4431"},{"key":"2020050713023712000_103.11.1539.90","doi-asserted-by":"crossref","unstructured":"Arumugam B , McBrien NA . Muscarinic Antagonist Control of Myopia: Evidence for M 4 and M 1 Receptor-Based Pathways in the Inhibition of Experimentally-Induced Axial Myopia in the Tree Shrew. Invest. Ophthalmol. Vis. Sci. 2012;53.doi:10.1167\/iovs.12-9943","DOI":"10.1167\/iovs.12-9943"},{"key":"2020050713023712000_103.11.1539.91","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/02713683.2014.967870","article-title":"The muscarinic antagonist MT3 distinguishes between form deprivation- and negative lens-induced myopia in chicks","volume":"40","author":"Nickla","year":"2015","journal-title":"Curr Eye Res"},{"key":"2020050713023712000_103.11.1539.92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.1987.tb00760.x"},{"key":"2020050713023712000_103.11.1539.93","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/eye.2014.208","article-title":"Accommodation-induced intraocular pressure changes in progressing myopes and emmetropes","volume":"28","author":"Yan","year":"2014","journal-title":"Eye"},{"key":"2020050713023712000_103.11.1539.94","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1442-9071.2011.02683.x","article-title":"Insulin-like growth factor-2 antisense oligonucleotides inhibits myopia by expression blocking of retinal insulin-like growth factor-2 in guinea pig","volume":"40","author":"Tang","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"2020050713023712000_103.11.1539.95","doi-asserted-by":"crossref","unstructured":"Chun RKM , Shan SW , Lam TC , et al . Cyclic adenosine monophosphate activates retinal apolipoprotein A1 expression and inhibits myopic eye growth. Invest Ophthalmol Vis Sci 2015;56.doi:10.1167\/iovs.14-14233","DOI":"10.1167\/iovs.14-14233"},{"key":"2020050713023712000_103.11.1539.96","first-page":"932","article-title":"Influence of astaxanthin in refractive status and pathohistology of myopia models caused by concave lens of guinea pigs","volume":"43","author":"Shi","year":"2017","journal-title":"Journal of Jilin University Medicine Edition"},{"key":"2020050713023712000_103.11.1539.97","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1167\/iovs.16-20694","article-title":"A bioengineering approach to myopia control tested in a guinea pig model","volume":"58","author":"Garcia","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713023712000_103.11.1539.98","first-page":"19","article-title":"Mechanism of the DL-alpha-aminoadipic acid inhibitory effect on form-deprived myopia in guinea pig","volume":"6","author":"Mao","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"2020050713023712000_103.11.1539.99","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4838(99)00279-4"},{"key":"2020050713023712000_103.11.1539.100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.exer.2014.07.022","article-title":"Effects of a human VEGF antibody (bevacizumab) on deprivation myopia and choroidal thickness in the chicken","volume":"127","author":"Mathis","year":"2014","journal-title":"Exp Eye Res"},{"key":"2020050713023712000_103.11.1539.101","doi-asserted-by":"crossref","unstructured":"Chen M , Qian Y , Dai J , et al . The sonic hedgehog signaling pathway induces myopic development by activating matrix metalloproteinase (MMP)-2 in Guinea pigs. PLoS One 2014;9:e96952.doi:10.1371\/journal.pone.0096952","DOI":"10.1371\/journal.pone.0096952"},{"key":"2020050713023712000_103.11.1539.102","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ebiom.2017.02.021","article-title":"Amphiregulin antibody and reduction of axial elongation in experimental myopia","volume":"17","author":"Jiang","year":"2017","journal-title":"EBioMedicine"},{"key":"2020050713023712000_103.11.1539.103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/786870","article-title":"Anti-VEGF treatment strategies for wet AMD","volume":"2012","author":"Kovach","year":"2012","journal-title":"J Ophthalmol"},{"key":"2020050713023712000_103.11.1539.104","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10792-017-0536-0","article-title":"Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy","volume":"38","author":"Barth","year":"2018","journal-title":"Int Ophthalmol"},{"key":"2020050713023712000_103.11.1539.105","doi-asserted-by":"publisher","DOI":"10.1242\/dev.01298"},{"key":"2020050713023712000_103.11.1539.106","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/jop.2015.0053","article-title":"Effect of bilberry extract on development of Form-Deprivation myopia in the guinea pig","volume":"32","author":"Deng","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"2020050713023712000_103.11.1539.107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtcms.2016.07.005","article-title":"Scleral TGF-\u03b21 and Smad3 expression is altered by TCM BU jing Yi SHI tablets in guinea pigs with form-deprivation myopia","volume":"3","author":"Mo","year":"2016","journal-title":"Journal of Traditional Chinese Medical Sciences"},{"key":"2020050713023712000_103.11.1539.108","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000313559","article-title":"Effect of black-currant extract on negative lens-induced ocular growth in chicks","volume":"44","author":"Iida","year":"2010","journal-title":"Ophthalmic Res"},{"key":"2020050713023712000_103.11.1539.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2003.11.002"},{"key":"2020050713023712000_103.11.1539.110","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0134"},{"key":"2020050713023712000_103.11.1539.111","unstructured":"Sertkaya A , Birkenbach A , et al . Examination of clinical trial costs and barriers for drug development, 2014."},{"key":"2020050713023712000_103.11.1539.112","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1427"},{"key":"2020050713023712000_103.11.1539.113","doi-asserted-by":"crossref","unstructured":"Bozic I , Reiter JG , Allen B , et al . Evolutionary dynamics of cancer in response to targeted combination therapy. Elife 2013;2:e00747.doi:10.7554\/eLife.00747","DOI":"10.7554\/eLife.00747"},{"key":"2020050713023712000_103.11.1539.114","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199307000-00003"},{"key":"2020050713023712000_103.11.1539.115","unstructured":"Chiang MF , Kouzis A , Pointer RW , et al . Treatment of childhood myopia with atropine eyedrops and bifocal spectacles. Binocul Vis Strabismus Q 2001;16."},{"key":"2020050713023712000_103.11.1539.116","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2016.12.061","article-title":"Different roles of retinal dopamine in albino guinea pig myopia","volume":"639","author":"Mao","year":"2017","journal-title":"Neurosci Lett"},{"key":"2020050713023712000_103.11.1539.117","doi-asserted-by":"publisher","DOI":"10.1177\/1535370216638773"},{"key":"2020050713023712000_103.11.1539.118","first-page":"2824","article-title":"Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs","volume":"17","author":"Dong","year":"2011","journal-title":"Mol Vis"},{"key":"2020050713023712000_103.11.1539.119","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1167\/iovs.17-22337","article-title":"The adenosine receptor antagonist, 7-methylxanthine, alters Emmetropizing responses in infant macaques","volume":"59","author":"Hung","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713023712000_103.11.1539.120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1755-3768.2009.01688.x","article-title":"Effects of 7-methylxanthine on the sclera in form deprivation myopia in guinea pigs","volume":"89","author":"Cui","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"2020050713023712000_103.11.1539.121","first-page":"1","article-title":"GABA b> Receptor Antagonist CGP46381 Inhibits Form-Deprivation Myopia Development in Guinea Pigs","volume":"2015","author":"Cheng","year":"2015","journal-title":"BioMed Research International"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-313798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:13:03Z","timestamp":1721275983000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-313798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":121,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,10,23]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bjophthalmol-2018-313798"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313798","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]}}}